RTW Investments, LP and Roderick Wong filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 103,509,730 ordinary shares of Zai Lab Limited as of September 30, 2026.
Key Highlights
- Aggregate beneficial ownership: RTW Investments, LP and Roderick Wong each report beneficial ownership of 103,509,730 ordinary shares of Zai Lab Limited.
- Percentage of class: The 103,509,730 shares represent 9.2% of the class, calculated based on 1,122,662,280 shares outstanding as of July 31, 2026.
- No sole voting or dispositive power: Both reporting persons report 0 shares held with sole voting power or sole dispositive power; all 103,509,730 shares are held with shared voting and shared dispositive power.
- Shares held through RTW Funds: According to the filing, the shares are directly held by funds advised by RTW Investments, LP, referred to as the "RTW Funds."
- Triggering event date: The date of the event requiring this filing is stated as September 30, 2026.
- Security described: The filing covers ordinary shares with a par value of $0.000006 per share, CUSIP number 98887Q104 assigned to the American Depositary Shares, with each ADS representing ten ordinary shares.
RTW Investments and Roderick Wong Disclose 9.2% Beneficial Ownership in Zai Lab as of September 30, 2026
RTW Investments, LP, a Delaware limited partnership serving as investment adviser to the RTW Funds, and Roderick Wong, M.D., the Managing Partner and Chief Investment Officer of RTW Investments, jointly filed Amendment No. 1 to a Schedule 13G with the SEC on November 16, 2026. The filing identifies Zai Lab Limited as the issuer and covers the issuer's ordinary shares, par value $0.000006 per share. The business address for both reporting persons is listed as 40 10th Avenue, Floor 7, New York, New York 10014.
According to the filing, both RTW Investments and Dr. Wong report aggregate beneficial ownership of 103,509,730 shares, representing 9.2% of the class. The percentage was calculated using 1,122,662,280 shares outstanding as of July 31, 2026, as reported in Zai Lab's Quarterly Report on Form 10-Q filed with the SEC on August 6, 2026. The filing notes that CUSIP number 98887Q104 is assigned to the American Depositary Shares of the issuer, with each ADS representing ten ordinary shares.
The filing states that all 103,509,730 shares are held with shared voting power and shared dispositive power, with neither reporting person holding any shares under sole voting or sole dispositive authority. The RTW Funds are identified as having "the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares reported herein." The filing also includes a certification that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
What Was Disclosed
RTW Investments, LP and Roderick Wong, M.D. filed an amended Schedule 13G disclosing combined beneficial ownership of 103,509,730 ordinary shares of Zai Lab Limited, equal to 9.2% of the class, with all shares held on a shared voting and shared dispositive basis through the RTW Funds.




Please wait processing your request...